Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Catherine J. Arnold

Partner
 
Catherine has earned her reputation as a biopharmaceutical thought leader and gained the trust of C-Suite and Board Members of life science companies having spent more than 25 years engaging with them. Her perspective is differentiated as a result of her diverse experience, having been a public equity investor for one of the world’s largest asset managers, an industry executive, a top-ranked sell-side analyst, and a clinician at a large university medical center. These roles gave her relevant experience for our Healthcare Practice in that she identified and negotiated innovative business development transactions, vetted public offerings and M&A deals, debated and help define corporate strategy, determined valuation and shaped governance policy and practice, which influenced institutional investments and shareholder returns.

Ms. Arnold’s recent life science transactions and advisory include:
  • The $40bn acquisition by AstraZeneca of Alexion
  • $12.5bn sale of Biohaven to Pfizer with simultaneous spin of neuroscience assets into a new publicly traded company
  • $11.5bn sale of Acceleron to Merck
  • $6.7bn acquisition of Arena Pharmaceuticals by Pfizer
  • Sanofi’s strategic review and bid for Horizon Therapeutics, ultimately acquired by Amgen for $28bn
  • Pfizer’s spin out of select autoimmune assets
Prior to joining Centerview, Catherine served as Managing Director, Portfolio Manager and Biopharmaceuticals Global Industry Analyst at Wellington Management in Boston, Massachusetts. In this role she regularly engaged with healthcare executives and boards on strategy, industry dynamics, capital markets and science. While at Wellington, she served as an active member of the firm’s Investment Stewardship Committee, charged with recommending philosophy, process and action on firm ESG matters. Prior to Wellington, Catherine spent more than a decade as a top-rated sell-side analyst at Credit Suisse and Sanford C. Bernstein & Co., covering the biopharmaceutical sector. Earlier in her career, Ms. Arnold served as the Director of Business Development and Strategic Planning at Hoffman-La Roche Pharmaceuticals and as a Senior Associate in the Biopharma Management Consulting Practice at Booz Allen Hamilton. Ms. Arnold has served on the Advisory Board for the FDA Modernization Task Force of The Center for Health Transformation, a member of the Health Forum of the Aspen Institute and was a Director of the National Board of the Cancer Support Community. She has contributed to Columbia Business School’s Healthcare and Pharmaceutical Management Program and has served as a Series Guest Lecturer at Harvard Business School.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Dave.com
Announced: Q1 2024
Status: Closed

Exclusive financial advisor to Dave on its repurchase of a convertible note from FTX
View All
New York

Centerview Partners LLC


31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax
London

Centerview Partners UK LLP


100 Pall Mall

3rd Floor

London SW1Y 5NQ

02074099700 | Tel
02074099704 | Fax
Paris

Centerview Partners France SCS


51 Avenue Hoche


Paris 75008

0180200620 | Tel
0180200621 | Fax
Menlo Park

Centerview Partners LLC


1302 El Camino Real

Suite 350

Menlo Park, California 94025

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC


555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax





Copyright © 2008 - 2024 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC